• Gio. Mag 30th, 2024

Investigational New Drug

  • Home
  • mRna, MD Anderson and CureVac enter strategic collaboration to develop novel cancer vaccines

mRna, MD Anderson and CureVac enter strategic collaboration to develop novel cancer vaccines

The University of Texas MD Anderson Cancer Center and CureVac N.V. today announced a co-development and licensing agreement to develop novel mRNA-based cancer vaccines. The collaboration creates strong synergies between…